Antimicrobial activity of meropenem against main bacterial species isolated from patient blood in 2006

Japanese Journal of Antibiotics

Volumn 60, Issue 6, 2007, Pages 378-386

  Kobayashi, Yoshio ^a   Sumitani, Yuko ^a   Sugita, Kayoko ^a   Katohno, Yasuhiro ^a  

^a KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; BIAPENEM; CARBAPENEM; CEFEPIME; CEFOTIAM; CEFTAZIDIME; CIPROFLOXACIN; DORIPENEM; FLOMOXEF; GATIFLOXACIN; GENTAMICIN; HABEKACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PANIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD; BROTH DILUTION; CONTROLLED STUDY; DRUG POTENCY; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHARMACOEPIDEMIOLOGY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BLOOD; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; HUMANS; JAPAN; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA; THIENAMYCINS; TIME FACTORS;

EID: 38549164601     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chemotherapy 40 (Suppl.1): 74-89, 1992
2. Japanese source
3. Japanese source
4. Japanese source
5. Japanese source
6. Japanese source
7. Chemotherapy 38: 102-105, 1990
8. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; Sixteenth informational supplement. Vol. 26, No. 3, M100-S16, Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, 2006
9. Japanese source
10. Japanese source
11. WALSH, T. R.; A. BOLMSTROM, A. QWARNSTROM, et al.: Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J. Clin. Microb. 40: 2755-2759, 2002
12. Jpn. J. Antibiotics 59: 428-451, 2006
13. Jpn. J. Antibiotics 53: 479-511, 2002
14. Japanese source
15. Japanese source
16. Japanese source
17. KIMURA, S.; J. ALBA, K. SHIROTO, et al.: Clonal diversity of metallo-β-lactamase-possessing Pseudomonas aeruginosa in geographically diverse regions of Japan. J. Clin. Microbiol. 43: 458-461, 2005
18. JONES, R. N.; L. M. DESHPANDE, J. M. BELL, et al.: Evaluation of the contemporary occurrence rates of metallo-β-lactamases in multidrug-resistant Gram-negative bacilli in Japan: Report from the SENTRY antimicrobial surveillance program (1998-2002). Diagn. Microbiol. Infect. Dis. 49: 289-294, 2004
19. Jpn. J. Antibiotics 58: 655-689, 2005
20. MORINAKA, A.; A. SHIMIZU & Y. SANBONGI: Expression of OprD and MexAB-OprM in clinical isolates of metallo-β- lactamase producing Pseudomonas aeruginosa in Japan. 10th Western Pacific Congress on Chemotherapy and Infectious Diseases 2006; P2-045.
21. Japanese source
22. MUTNICK, A. H.; P. R. RHOMBERG, H. S. SADER, et al.: Antimicrobial usage and resistance trend relationships from MYSTIC programme in North America (1999-2001). J. Antimicrob. Chemother. 53: 290-296, 2004